Details for New Drug Application (NDA): 062303
✉ Email this page to a colleague
The generic ingredient in RIFADIN is rifampin. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the rifampin profile page.
Summary for 062303
Tradename: | RIFADIN |
Applicant: | Sanofi Aventis Us |
Ingredient: | rifampin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062303
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 150MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription